Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-28 Sale | 2024-10-28 9:48 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 131,687 | $76.61 | $10,089,164 | 302,366 (Direct) | View |
| 2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 16,136 | $57.15 | $922,212 | 187,052 (Direct) | View |
| 2024-05-03 Sale | 2024-05-03 8:51 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 66,756 | $74.69 | $4,986,008 | 239,105 (Direct) | View |
| 2024-01-04 Sale | 2024-01-04 9:35 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 15,000 | $17.9 | $268,500 | 335,730 (Direct) | View |
| 2023-04-17 Sale | 2023-04-18 7:07 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $20 | $150,000 | 149,279 (Direct) | View |
| 2023-04-11 Sale | 2023-04-13 5:13 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 97,839 | $18 | $1,761,310 | 366,823 (Direct) | View |
| 2023-03-30 Sale | 2023-04-03 7:24 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 161,940 | $17.19 | $2,784,219 | 149,279 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 94,001 | $0 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 26,000 | $5.8 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 4,251 | $4.68 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 12,750 | $7.77 | 302,366 (Direct) | View |
| 2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 51,000 | $8.52 | 302,366 (Direct) | View |
| 2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 28,334 | $0 | 187,052 (Direct) | View |
| 2024-05-03 Exercise | 2024-05-03 8:51 pm | 2021-03-31 2030-03-31 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 34,249 | $0 | 239,105 (Direct) | View |
| 2024-05-03 Exercise | 2024-05-03 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 4,249 | $4.68 | 239,105 (Direct) | View |
| 2024-05-03 Exercise | 2024-05-03 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 30,000 | $4.88 | 239,105 (Direct) | View |
| 2024-03-27 Tax Withholding | 2024-03-27 8:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 16,610 | $83.34 | 207,361 (Direct) | View |
| 2024-03-27 Option Award | 2024-03-27 8:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 31,667 | $0 | 207,361 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 7:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 20,093 | $85.22 | 192,304 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 7:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 31,667 | $0 | 192,304 (Direct) | View |
| 2024-01-04 Tax Withholding | 2024-01-04 9:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 13,872 | $18.58 | 335,730 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-04 9:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 49,122 | $17.4 | 335,730 (Direct) | View |
| 2024-01-03 Option Award | 2024-01-04 9:35 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 253,334 | $0 | 335,730 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:07 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $13.07 | 149,279 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-18 7:07 pm | 2018-08-31 2028-08-31 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $0 | 149,279 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 97,839 | $0 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 52,000 | $5.8 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 8,500 | $4.68 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 30,000 | $4.88 | 366,823 (Direct) | View |
| 2023-04-11 Exercise | 2023-04-13 5:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,339 | $7.77 | 366,823 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 55,166 | $17.57 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | 2020-01-15 2029-01-15 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 124,661 | $0 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 42,000 | $7.69 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 12,250 | $4.65 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 7,500 | $4.12 | 149,279 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 30,911 | $7.77 | 149,279 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 56,667 | $0 | 149,279 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 7:24 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 32,000 | $8.52 | 149,279 (Direct) | View |
| 2022-12-30 Tax Withholding | 2023-01-04 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 19,697 | $9.4 | 389,057 (Direct) | View |
| 2023-01-04 Tax Withholding | 2023-01-04 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 20,708 | $8.42 | 389,057 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-04 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 23,933 | $8.52 | 389,057 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 6:25 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 314,900 | $0 | 389,057 (Direct) | View |
| 2022-01-04 Tax Withholding | 2022-01-05 7:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 8,835 | $4.62 | 256,304 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:13 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 173,333 | $0 | 256,304 (Direct) | View |
| 2022-01-03 Tax Withholding | 2022-01-05 7:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 3,097 | $4.88 | 256,304 (Direct) | View |
| 2021-09-28 Tax Withholding | 2021-09-30 5:43 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 2,306 | $6.5 | 94,485 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 5:43 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 6,667 | $0 | 94,485 (Direct) | View |
| 2021-01-19 Tax Withholding | 2021-01-19 6:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 808 | $6.68 | 89,751 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 2,787 | $5.8 | 168,559 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 149,450 | $0 | 168,559 (Direct) | View |
Ownership | 2021-01-06 4:22 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 0 | $0 | 191,146 (Direct) | View |